Unknown

Dataset Information

0

BxPC-3-Derived Small Extracellular Vesicles Induce FOXP3+ Treg through ATM-AMPK-Sirtuins-Mediated FOXOs Nuclear Translocations.

ABSTRACT: Immunotherapy in pancreatic ductal adenocarcinoma (PDAC) treatment faces serious challenges, due particularly to the poor immunogenicity. Cancer cell-derived small extracellular vesicles (sEVs) play important roles in damaging the immune system. However, the effects of pancreatic cancer-derived sEVs on T lymphocytes are unknown. Here we investigated changes in phenotypes and signal transduction pathways in sEVs-treated T lymphocytes. We identified the overexpression of immune checkpoint proteins PD-1, PD-L1, CTLA4, and Tim-3 and the enrichment of FOXP3+ Treg cluster in sEVs-treated T lymphocytes by CyTOF. Gene set enrichment analysis revealed that DNA damage response and metabolic pathways might be involved in sEVs-induced Tregs. ATM, AMPK, SIRT1, SIRT2, and SIRT6 were activated sequentially in sEVs-treated T lymphocytes and essential for sEVs-upregulated expressions of FOXO1A, FOXO3A, and FOXP3. Our study reveals the impact and mechanism of pancreatic cancer cell-derived sEVs on T lymphocytes and may provide insights into developing immunotherapy strategies for PDAC treatment.

SUBMITTER: Shen T 

PROVIDER: S-EPMC7452591 | biostudies-literature | 2020 Aug

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

BxPC-3-Derived Small Extracellular Vesicles Induce FOXP3+ Treg through ATM-AMPK-Sirtuins-Mediated FOXOs Nuclear Translocations.

Shen Tao T   Jia Shengnan S   Ding Guoping G   Ping Dongnan D   Zhou Liangjing L   Zhou Senhao S   Cao Liping L  

iScience 20200802 8

Immunotherapy in pancreatic ductal adenocarcinoma (PDAC) treatment faces serious challenges, due particularly to the poor immunogenicity. Cancer cell-derived small extracellular vesicles (sEVs) play important roles in damaging the immune system. However, the effects of pancreatic cancer-derived sEVs on T lymphocytes are unknown. Here we investigated changes in phenotypes and signal transduction pathways in sEVs-treated T lymphocytes. We identified the overexpression of immune checkpoint proteins  ...[more]

Similar Datasets

Unknown Targeted De-Methylation of the FOXP3-TSDR Is Sufficient to Induce Physiological FOXP3 Expression but Not a Functional Treg Phenotype.
| S-EPMC7817622 | biostudies-literature
Unknown Polyclonal CD4+Foxp3+ Treg cells induce TGF?-dependent tolerogenic dendritic cells that suppress the murine lupus-like syndrome.
| S-EPMC3523557 | biostudies-literature
Unknown ICOSL expressed in triple-negative breast cancer can induce Foxp3+ Treg cell differentiation and reverse p38 pathway activation.
| S-EPMC9548022 | biostudies-literature
Unknown Changes in natural Foxp3(+)Treg but not mucosally-imprinted CD62L(neg)CD38(+)Foxp3(+)Treg in the circulation of celiac disease patients.
| S-EPMC3709933 | biostudies-literature
Unknown Histone/protein deacetylase 11 targeting promotes Foxp3+ Treg function.
| S-EPMC5561267 | biostudies-literature
Unknown FOXP3(+) Treg Cells and Gender Bias in Autoimmune Diseases.
| S-EPMC4585344 | biostudies-literature
Unknown Dynamic Foxp3-chromatin interaction controls tunable Treg cell function.
| S-EPMC11211070 | biostudies-literature
Unknown GATA3, HDAC6, and BCL6 Regulate FOXP3+ Treg Plasticity and Determine Treg Conversion into Either Novel Antigen-Presenting Cell-Like Treg or Th1-Treg.
| S-EPMC5790774 | biostudies-literature
Unknown Antigen-non-specific regulation centered on CD25+Foxp3+ Treg cells.
| S-EPMC3094156 | biostudies-other
Unknown Cancer-FOXP3 directly activated CCL5 to recruit FOXP3<sup>+</sup>Treg cells in pancreatic ductal adenocarcinoma.
| S-EPMC5454319 | biostudies-literature